Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
GCLC Truncation and Delayed Age-Related Cataract
2026-09-15
Wei et al. identify age-related truncation of GCLC at Asp499 as a potential molecular explanation for declining lens glutathione and demonstrate that preventing this event delays cataract formation in mice. Their D499E knock-in model links preservation of GCLC integrity with improved redox protection, while also highlighting the need for human validation before therapeutic translation.
-
GPER1 as a Chemoprevention Target in Prostate Cancer
2026-09-15
The reference study identifies GPER1 as a potentially protective receptor during the transition from high-grade prostatic intraepithelial neoplasia to prostate cancer. Using human samples, public datasets, TRAMP mice, and cell-based pharmacology and gene-silencing experiments, it shows that GPER1 activation suppresses tumor progression and epithelial-to-mesenchymal transition, while loss of GPER1 promotes invasive behavior.
-
OTUD3–SLC7A11 Axis in Sunitinib-Resistant ccRCC
2026-09-14
The reference study identifies OTUD3 as a driver of sunitinib resistance in clear cell renal cell carcinoma by stabilizing the cystine transporter SLC7A11 and suppressing ferroptosis. Its findings connect deubiquitination, cystine utilization, redox control, and drug response, suggesting that OTUD3–SLC7A11 signaling may be a mechanistic target for restoring sunitinib sensitivity.
-
Type III Collagen Restricts Breast Cancer Progression
2026-09-14
Stewart and colleagues identify type III collagen (Col3) as a tumor-restrictive component of the breast cancer microenvironment rather than simply a structural matrix protein. By integrating fibroblast-derived matrices, three-dimensional cultures, patient biopsy analysis, TCGA bioinformatics, and mouse models, the study links higher Col3 relative to type I collagen with reduced tumor aggressiveness and improved survival.
-
Cy5-UTP for Precision RNA Probe Synthesis
2026-09-13
Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH, expression arrays, and mechanistic RNA studies without a separate staining step. This guide connects practical T7 transcription workflows with single-molecule labeling insights, helping researchers tune incorporation, signal, and probe quality.
-
HLY78 Wnt/β-Catenin Pathway Modulator Workflow
2026-09-12
HLY78 provides a ligand-dependent way to enhance Wnt/β-catenin signaling through Axin-LRP6 coupling, making it useful for developmental, stem-cell, and pathway-rescue experiments. This guide translates its mechanism into practical cell and zebrafish workflows while separating validated findings from exploratory assay recommendations.
-
Neuromedin S (rat): Practical GPCR Assay Guide
2026-09-12
Neuromedin S (rat) provides a chemically defined rat peptide ligand for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. It is intended for laboratory research with validated assay controls, not for diagnostic, therapeutic, medical, or clinical use.
-
CCK8 for Translational Ovarian Cancer Research
2026-09-11
Discover how Cell Counting Kit-8 (CCK-8) can connect PLIN2-driven macrophage biology with practical cell viability, proliferation, and drug-response decisions in ovarian cancer research.
-
WST-8 Glucose Uptake Assay in NAFLD
2026-09-11
Discover how the WST-8 Glucose Uptake Assay Kit can functionally test insulin-resistance phenotypes in NAFLD models. This article connects 2-deoxyglucose flux measurements with the Galectin-1–FIP200 autophagy mechanism while clarifying assay interpretation, controls, and limitations.
-
YTHDF2, m6A Decay, and Hippocampal Memory
2026-09-10
A 2025 Advanced Science study identifies YTHDF2-mediated degradation of m6A-marked mRNAs as a causal regulator of hippocampus-dependent learning and memory. Forebrain YTHDF2 loss increased synaptic transmission and activity-dependent protein synthesis, while YTHDF2 restoration or SEMA4B reduction reversed the memory enhancement, providing a mechanistic framework for studying RNA regulation in neural plasticity.
-
Recombinant Mouse M-CSF: Assay Workflows
2026-09-10
Build more consistent macrophage cultures, osteoclast progenitor assays, and fibrosis-focused experiments with a tag-free mouse cytokine. This guide connects practical M-CSF handling with the IGF2BP1–THBS1–TLR4 findings reported in pulmonary fibrosis research.
-
Bestatin (Ubenimex): Applied Research Workflows
2026-09-09
Bestatin (Ubenimex) combines a defined aminopeptidase selectivity profile with practical utility in enzyme assays, multidrug resistance research, and apoptosis workflows. This guide translates structural evidence into reproducible preparation, dosing, controls, and troubleshooting strategies.
-
Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies
2026-09-09
Jorge and colleagues show that parthenolide reduces metabolic activity and promotes oxidative-stress-associated apoptosis across diverse B- and T-lineage lymphoid malignancy models. The study is valuable because it connects a resazurin-based viability readout with mitochondrial, redox, apoptotic, NF-κB, and gene-expression measurements, while also demonstrating strong cell-line-dependent responses.
-
Curcumin, NLRP3, and Endothelial Pyroptosis
2026-09-08
The reference study shows that curcumin protects human umbilical vein endothelial cells from H2O2-induced injury by suppressing NLRP3-associated pyroptosis and improving endothelial functional markers. Its use of caspase-1 and NLRP3 inhibitors strengthens the mechanistic interpretation, while the model provides a useful framework for studying oxidative endothelial dysfunction relevant to atherosclerosis.
-
Tetrazolium (chloride) for Viability Assays
2026-09-07
Tetrazolium (chloride), also called Tetrazolium Red, converts reductive enzyme activity into a visible formazan signal for cell and tissue analysis. This guide shows how to pair quantitative cell assays with ischemic brain staining, interpret mitochondrial readouts, and troubleshoot weak or misleading color development.